Cytodyn Inc (CYDY)

[z_smith]

One other thought about the comps to TaiMed. TaiMed had a market cap of $1.2B when they were at the stage PRO-140 is now.

The differences between the companies at this stage were / are:
Positive for TaiMed:
1) TaiMed had plenty of cash
2) TaiMed had a fully fleshed-out company vs. the bare-bones outfit + outsourcing that CYDY uses
3) TaiMed was trading on legitimate exchange (Taipei)
4) TaiMed wasn't raising money in the bush-leagues (i.e. Paulson)

Negative for TaiMed:
5) TaiMed only had 30 patients in their P3 trial
6) Didn't have the number of patients to establish safety anywhere near PRO-140
7) Didn't have any public objective or initiative re: Mono

***

And it should be noted that shortly after TaiMed announced filing of their BLA, the market cap rose to ~$1.6B.

TaiMed was approved by the FDA in March, 2018. Now the market cap is the current USD$2.2B.

***

If CYDY can get their act together regarding funding, then there should be a lot of room to run on this stock. IMO.